Fig.1From: Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseasesThe difference between the GnRH-a treated or untreated patients regarding POI rate in survivors did not reach statistical significance for the study population. POI, premature ovarian insufficiency; COF, cyclic ovarian functionBack to article page